Green light for UK trial of nasal coronavirus vaccine
The trial is expected to begin next month, with first data anticipated in the second quarter of 2021
Read More
Tag: COVI-VAC
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
- PharmaTimes MSEA and NIEA awards are open for entry
- BBSRC invests £48m in Babraham Institute to advance lifelong health research
